Diagnosis, Individual, Manufacturing and Screening

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

FDA Law

AUGUST 23, 2022

These practical benefits are in marked contrast to molecular COVID-19 tests that are used for definitive diagnosis and are generally expected to detect the SARS-CoV-2 virus at least 95% of the time when someone is infected. The low viral loads were most likely due to individuals infected with the Omicron variant.

Individual

Individual Clinic Healthcare Provider

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

JUNE 20, 2024

Incontinence and avoiding issues can present in an older individual, in some cases, just like they do a younger person. Biological aging or physiological aging varies from individual to individual. How do you think about this from a clinical perspective when you’re seeing individuals in your office? Everybody ages.

IT Patient-Centered Patients Clinic

Where Are All the OTC Rapid Antigen Tests for COVID? FDA’s Role in Blocking These Tests from the American Market

FDA Law

NOVEMBER 18, 2021

Rapid tests for COVID-19 are fast, inexpensive to manufacture, and a relatively easy method to detect the presence of an active SARS?CoV?2 The tests are very accurate in detecting individuals with a relatively high viral load (symptomatic or not). A positive result, however, is treated as a screen. 2 infection. day turnaround.

Screening

Screening Manufacturing Healthcare IT

Primary Care Digest

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

Urinary Incontinence Revisited: George Kuchel & Alison Huang

Where Are All the OTC Rapid Antigen Tests for COVID? FDA’s Role in Blocking These Tests from the American Market

Stay Connected